These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 11319374)

  • 41. [Management of erysipelas].
    Granier F
    Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 2):429-42. PubMed ID: 11319375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute bacterial skin infections and cellulitis.
    Gabillot-Carré M; Roujeau JC
    Curr Opin Infect Dis; 2007 Apr; 20(2):118-23. PubMed ID: 17496568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Bacterial acute non necrosing cellulitis (erysipelas) in adult].
    Dezoteux F; Staumont-Sallé D
    Rev Med Interne; 2021 Mar; 42(3):186-192. PubMed ID: 33176944
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Compression is important in erysipelas treatment].
    Villefrance M; Høgh A; Kristensen LH
    Ugeskr Laeger; 2017 Oct; 179(41):. PubMed ID: 28992840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibiotic use in patients with erysipelas: a retrospective study.
    Bishara J; Golan-Cohen A; Robenshtok E; Leibovici L; Pitlik S
    Isr Med Assoc J; 2001 Oct; 3(10):722-4. PubMed ID: 11692544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trends in the epidemiology of erysipelas in Slovenia.
    Sočan K; Sočan M
    Acta Dermatovenerol Alp Pannonica Adriat; 2018 Mar; 27(1):1-4. PubMed ID: 29589637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Bacterial cutaneous infections: erysipelas. Etiology, diagnosis, clinical course amd treatment].
    Crickx B
    Rev Prat; 1993 Apr; 43(7):876-8. PubMed ID: 8346404
    [No Abstract]   [Full Text] [Related]  

  • 48. [Evaluation of general practitioners' knowledge about diagnostic and therapeuthic management of erysipelas in the city of Marrakech].
    Ihbibane F; Arsène NL; Adarmouch L; Amine M; Tassi N
    Pan Afr Med J; 2018; 29():41. PubMed ID: 29875923
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anal colonization of group G beta-hemolytic streptococci in relapsing erysipelas of the lower extremity.
    Eriksson BK
    Clin Infect Dis; 1999 Nov; 29(5):1319-20. PubMed ID: 10524984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Bacterial skin infections: impetigo, furunculosis, erysipelas. Etiology, diagnosis, clinical course, treatment].
    Ann Dermatol Venereol; 2000 Oct; 127(Spec No 1):A98-103. PubMed ID: 11474537
    [No Abstract]   [Full Text] [Related]  

  • 51. Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study.
    Ekelund K; Skinhøj P; Madsen J; Konradsen HB
    J Clin Microbiol; 2005 Apr; 43(4):1789-96. PubMed ID: 15815000
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Survey of general practitioners management of erysipelas].
    Larivière D; Blavot-Delépine A; Fantin B; Lefort A
    Rev Med Interne; 2011 Dec; 32(12):730-5. PubMed ID: 21862184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical aspects and treatment of erysipelas].
    Tarasov VI; Salmanova MA
    Voen Med Zh; 1983 Aug; (8):67-8. PubMed ID: 6636586
    [No Abstract]   [Full Text] [Related]  

  • 54. Severe relapsing erysipelas associated with chronic Streptococcus agalactiae vaginal colonization.
    Del Giudice P; van der Mee-Marquet N; David-Rubin F; Le Duff F; Benchia K; Counillon E; Domelier AS; Quentin R
    Clin Infect Dis; 2006 Oct; 43(7):e67-70. PubMed ID: 16941357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Helicobacter cinaedi-associated bacteraemia and erysipelas in an immunocompetent host: a diagnostic challenge.
    Van Genderen PJ; Goessens WH; Petit PL
    Scand J Infect Dis; 2005; 37(5):382-5. PubMed ID: 16051580
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Bacterial cutaneous infections: erysipelas. Etiology, diagnosis, development, treatment].
    Bernard P
    Rev Prat; 1996 Mar; 46(6):773-6. PubMed ID: 8731747
    [No Abstract]   [Full Text] [Related]  

  • 58. [Erysipelas. Recent data and current concept].
    Petit A
    Ann Dermatol Venereol; 1996; 123(9):585-93. PubMed ID: 9615117
    [No Abstract]   [Full Text] [Related]  

  • 59. Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands.
    Goettsch WG; Bouwes Bavinck JN; Herings RM
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):834-9. PubMed ID: 16898907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.